FZD7 and hepatocellular carcinoma: In fact, the overexpression of FZD7 was detected in 90% of tumors (most in the human hepatocellular carcinoma cells and in breast cancer cells) where causes the accumulation of β-catenin protein affecting the Wnt/β-catenin signal transduction pathway [66,67,68].